Publication | Closed Access

In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens

Health SciencesMedicineKlebsiella PneumoniaeInfectious Respiratory DiseaseRespiratory Tract PathogensAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyInfection ControlVitro ActivityNew FluoroquinolonePharmacologyAntimicrobial CompoundClinical MicrobiologyAntimicrobial ResistanceDrug Resistance